MedTrace Logo

Retinal Function in Diabetic Patients Without Retinopathy

NCT00839150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2011-09-19

No results posted yet for this study

Summary

The primary purpose was to assess, in diabetic patients without diabetic retinopathy and control subjects, color vision, contrast sensitivity, electroretinography, and flicker-induced vasodilatation using the Dynamic Vessel Analyzer, in order to specify the earliest impaired retinal cells in diabetes, and gain more insight into diabetic retinopathy pathogenesis.

Conditions

  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Pascale Massin, MD,Pr;PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2007-01-31
Completion
2007-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00839150 on ClinicalTrials.gov